tiprankstipranks
Ugro Capital Limited (IN:UGROCAP)
:UGROCAP
India Market
Want to see IN:UGROCAP full AI Analyst Report?

Ugro Capital Limited (UGROCAP) AI Stock Analysis

6 Followers

Top Page

IN:UGROCAP

Ugro Capital Limited

(UGROCAP)

Select Model
Select Model
Select Model
Neutral 49 (OpenAI - 5.2)
Rating:49Neutral
Price Target:
₹112.00
▼(-32.29% Downside)
Action:ReiteratedDate:04/22/26
The score is primarily weighed down by high leverage and historically unstable cash generation, with additional caution from mixed operating profitability signals. Technicals offer some near-term support (positive MACD, RSI ~61), but the longer-term trend remains weak (below 100/200 DMA). Valuation cannot be strongly assessed due to missing/zeroed P/E and absent dividend yield.
Positive Factors
Revenue growth
Sustained high top-line growth indicates expanding loan book scale and stronger origination momentum in the MSME segment. Over 2–6 months this supports higher core interest income, improved operating leverage as fixed costs spread, and a firmer revenue base for continued credit deployment.
Negative Factors
High leverage
Leverage materially exceeds historical levels and peer norms, constraining financial flexibility. For an NBFC, high debt-to-equity raises refinancing and interest-rate sensitivity, amplifies credit stress impact on capital ratios, and limits the firm's ability to absorb shocks while growing the loan book.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth
Sustained high top-line growth indicates expanding loan book scale and stronger origination momentum in the MSME segment. Over 2–6 months this supports higher core interest income, improved operating leverage as fixed costs spread, and a firmer revenue base for continued credit deployment.
Read all positive factors

Ugro Capital Limited (UGROCAP) vs. iShares MSCI India ETF (INDA)

Ugro Capital Limited Business Overview & Revenue Model

Company Description
UGRO Capital Limited, a non-banking financial company, engages in the lending business. It provides business loans to healthcare, education, chemicals, food processing/FMCG, hospitality, electrical equipment and components, auto components, and li...
How the Company Makes Money
Ugro Capital primarily makes money by originating MSME loans and earning interest income on the loan book (the spread between the yield on advances and its cost of borrowings). In addition to net interest income, it earns fee-based income from loa...

Ugro Capital Limited Financial Statement Overview

Summary
Top-line growth is a positive, but the balance sheet is highly levered (debt-to-equity ~3.55x) and cash flows have been historically volatile with multiple years of deeply negative operating/free cash flow before a 2026 rebound. Mixed profitability signals (negative EBIT/EBITDA margins despite positive net income) also raise earnings-quality concerns.
Income Statement
62
Positive
Balance Sheet
44
Neutral
Cash Flow
40
Negative
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue12.87B14.74B9.64B7.07B4.88B2.68B
Gross Profit3.34B2.23B1.29B995.24M678.77M624.11M
EBITDA3.83B-140.04M2.62B2.19B1.07B348.23M
Net Income1.55B1.75B1.44B1.19B397.76M145.51M
Balance Sheet
Total Assets107.79B140.75B91.68B62.80B43.06B28.54B
Cash, Cash Equivalents and Short-Term Investments15.99B18.25B5.53B883.64M2.12B1.60B
Total Debt80.88B103.24B69.04B46.53B31.49B18.31B
Total Liabilities83.16B111.69B71.22B48.42B33.22B18.88B
Stockholders Equity24.63B29.06B20.46B14.38B9.84B9.67B
Cash Flow
Free Cash Flow-669.50M1.71B-25.00B-15.38B-12.61B-11.46B
Operating Cash Flow-556.27M2.14B-24.74B-15.35B-12.20B-11.32B
Investing Cash Flow-3.88B-19.64B-799.24M-2.30B-845.42M413.80M
Financing Cash Flow15.07B27.51B26.55B18.14B12.79B10.23B

Ugro Capital Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price165.40
Price Trends
50DMA
110.58
Positive
100DMA
138.93
Negative
200DMA
157.05
Negative
Market Momentum
MACD
-1.19
Negative
RSI
63.93
Neutral
STOCH
92.65
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:UGROCAP, the sentiment is Neutral. The current price of 165.4 is above the 20-day moving average (MA) of 93.73, above the 50-day MA of 110.58, and above the 200-day MA of 157.05, indicating a neutral trend. The MACD of -1.19 indicates Negative momentum. The RSI at 63.93 is Neutral, neither overbought nor oversold. The STOCH value of 92.65 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:UGROCAP.

Ugro Capital Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
66
Neutral
₹33.68B23.710.92%9.70%28.71%
62
Neutral
₹15.65B4.3434.93%-65.44%
61
Neutral
₹15.64B18.43-6.16%-68.64%
51
Neutral
₹31.55B11.84-10.38%-200.85%
49
Neutral
₹16.46B6.6339.48%61.62%
44
Neutral
₹19.32B-5.67-55.39%-139.16%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:UGROCAP
Ugro Capital Limited
107.39
-71.64
-40.02%
IN:ARMANFIN
Arman Financial Services Limited
1,548.00
-77.85
-4.79%
IN:BFINVEST
BF Investment Limited
419.70
-79.20
-15.87%
IN:MUTHOOTMF
Muthoot Microfin Ltd
184.45
30.70
19.97%
IN:SPANDANA
Spandana Sphoorty Financial Ltd.
224.65
-51.24
-18.57%
IN:TFCILTD
Tourism Finance Corporation of India Limited
73.22
33.15
82.73%

Ugro Capital Limited Corporate Events

Ugro Capital files FY26 investor presentation on MSME lending performance
Apr 20, 2026
Ugro Capital Limited has submitted an investor presentation to the stock exchanges covering its results for the quarter and full financial year ended 31 March 2026. The presentation, which highlights the company’s data-tech led MSME lending ...
UGRO Capital Restructures MyShubhLife Deal to All-Cash Payout as Acquisition Nears Close
Mar 5, 2026
UGRO Capital has moved to close its acquisition of Datasigns Technologies, operator of the MyShubhLife platform, which it has already been using for 15 months to originate MSME and small merchant loans with assets under management of about ₹...
UGRO Capital Secures RBI Nod for Amalgamation of Profectus Capital
Feb 26, 2026
UGRO Capital has received a conditional ‘No Objection’ from the Reserve Bank of India for the proposed amalgamation of its wholly owned subsidiary, Profectus Capital Private Limited, into the parent company. The move is part of a large...
UGRO Capital Raises Rs. 50 Crore via Short-Term Unlisted Commercial Papers
Feb 25, 2026
UGRO Capital Limited has approved and completed the allotment of unlisted commercial papers amounting to Rs. 50 crore, with a face value of Rs. 5 lakh per instrument and an aggregate issue value of approximately Rs. 49.42 crore. The commercial pap...
UGRO Capital Releases Revised Q3 FY26 Investor Presentation on MSME Lending Business
Feb 7, 2026
UGRO Capital Limited has released a revised investor presentation covering the quarter and nine months ended 31 December 2025, in line with its disclosure obligations to stock exchanges. The updated presentation, made available to investors via th...
UGRO Capital Releases Revised Investor Presentation for Q3 and Nine Months FY26
Feb 7, 2026
UGRO Capital Limited has released a revised investor presentation for the quarter and nine months ended 31 December 2025, in line with disclosure requirements under SEBI’s Listing Obligations and Disclosure Requirements Regulations. The upda...
UGRO Capital Realigns MSME Lending Business to Boost Earnings Quality and Cut Costs
Feb 7, 2026
UGRO Capital has announced a strategic realignment of its business model aimed at improving earnings quality, operating efficiency and long-term capital sustainability, by shifting focus toward two core segments: emerging market secured lending th...
UGRO Capital Clears Q3 Results, Board Changes and Insider Trading Code Update
Feb 7, 2026
UGRO Capital’s board, at its meeting on 7 February 2026, approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, along with the statutory auditors’ limited review rep...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 22, 2026